Schedule 13D ownership disclosure

Summit Therapeutics plc

Security class unavailable · CUSIP: 86627R102

Event date: 2019-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-19-000328
Form type
SC 13D/A
Filer
LANSDOWNE PARTNERS
CIK
CIK 1608485
Filed
Jan 11, 2019
Reporting period
Jan 08, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub